V028-5753 Screening compound: 3,5-difluoro-N-[1-(2-{[2-(4-methoxyphenyl)ethyl]carbamoyl}phenyl)piperidin-4-yl]benzamide

V028-5753 Screening compound: 3,5-difluoro-N-[1-(2-{[2-(4-methoxyphenyl)ethyl]carbamoyl}phenyl)piperidin-4-yl]benzamide
V028-5753 Screening compound: 3,5-difluoro-N-[1-(2-{[2-(4-methoxyphenyl)ethyl]carbamoyl}phenyl)piperidin-4-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-5753
3,5-difluoro-N-[1-(2-{[2-(4-methoxyphenyl)ethyl]carbamoyl}phenyl)piperidin-4-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-5753

Molecular Formula

C28H29F2N3O3 (C28 H29 F2 N3 O3)

Compound Name

3,5-difluoro-N-[1-(2-{[2-(4-methoxyphenyl)ethyl]carbamoyl}phenyl)piperidin-4-yl]benzamide

IUPAC name

35-difluoro-N-[1-(2-{[2-(4-methoxyphenyl)ethyl]carbamoyl}phenyl)piperidin-4-yl]benzamide

SMILES

COc1ccc(CCNC(c(cccc2)c2N(CC2)CCC2NC(c2cc(F)cc(F)c2)=O)=O)cc1

InChI

InChI=1S/C28H29F2N3O3/c1-36-24-8-6-19(7-9-24)10-13-31-28(35)25-4-2-3-5-26(25)33-14-11-23(12-15-33)32-27(34)20-16-21(29)18-22(30)17-20/h2-9,16-18,23H,10-15H2,1H3,(H,31,35)(H,32,34)

InChI Key

BYUZGPLSSZLFTK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19894110

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

493.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.731

Distribution Coefficient, logD

4.731

Water Solubility, LogSw

-4.43

Polar Surface Area

59.135

Acid Dissociation Constant (pKa)

12.46

Base Dissociation Constant (pKb)

3.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

V028-5753 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V028-5753 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-5753?
Check Price and Availability of V028-5753, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-5753 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-5753
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-5753
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-5753 available by request